Toyama et al. [135] showed a few years ago that the administration of AT1 receptor antagonist telmisartan was able to improve the impaired relaxation to acetylcholine observed in the aorta of a genetic model of obesity in mice. This evidence concerns the gene AGTR1 and obesity due to melanocortin 4 receptor deficiency.